Shari Goldfarb

Oral minoxidil for late alopecia in cancer survivors

Abstract P4-11-03: Decisions and outcomes of young women with breast cancer regarding fertility preservation before cancer treatment and family building after treatment

Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency

A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors

A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Hair disorders in patients with cancer

Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer

Hair disorders in cancer survivors

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

Sexual health needs and educational intervention preferences for women with cancer

Erectile dysfunction

Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using ⁸⁹Zr-Trastuzumab PET/CT

How to ask and what to do

A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer

Sexual and Reproductive Health in Cancer Survivors

Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy